Myocardial extracellular matrix: an ever-changing and diverse entity

Area of Science:

• Cardiovascular Biology
• Glycobiology
• Extracellular Matrix Research

Background:

• The cardiac extracellular matrix (ECM) provides structural integrity and plasticity to the heart.
• The nonstructural ECM compartment includes glycoproteins, proteoglycans, and glycosaminoglycans, all modified by glycosylation.
• Glycosylation is crucial for ECM protein function in cardiac development, homeostasis, and remodeling.

Purpose of the Study:

• To review the fundamental role of the cardiac ECM from a glycobiology perspective.
• To explore how glycosylation influences ECM proteins during cardiac development and disease.
• To highlight the therapeutic potential of understanding ECM glycosylation in heart disease.

Main Methods:

• Literature review focusing on glycobiology and cardiac ECM.
• Analysis of the roles of specific glycoproteins, proteoglycans, and glycosaminoglycans in cardiac remodeling.
• Examination of how glycosylation affects protein function and ECM variability.

Main Results:

• Glycoproteins, proteoglycans, and glycosaminoglycans are upregulated post-cardiac injury.
• These molecules regulate key remodeling processes including inflammation, fibrosis, and angiogenesis.
• Individual ECM proteins can exhibit diverse or even opposing functions depending on conditions and glycosylation.

Conclusions:

• Glycosylation significantly alters the function of ECM proteins in the myocardium.
• The variability in cardiac ECM remodeling is tightly regulated by glycosylation.
• Targeting glycosylation pathways may offer novel therapeutic strategies for cardiovascular diseases.